Stay Alert for Skin Reactions With Allopurinol in Patients With CV Disease

December 2019

A new study will raise concerns about a possible increased risk of severe skin reactions with allopurinol in patients with CV disease....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Pneumonia Expect to See More Amoxicillin Rxs for Community-Acquired Pneumonia
E-Cigarettes Help Patients Break the E-Cigarette Habit
Migraine Don't Jump to a CGRP Antagonist for Migraine Prophylaxis
Immunizations Boost Immunization Rates for Immunocompromised Patients
Med Safety Stay Alert for Skin Reactions With Allopurinol in Patients With CV Disease
Antimicrobial Stewardship Take the Lead in Promoting Outpatient Antimicrobial Stewardship
Diabetes Meds Dispel Concerns About CV Safety With Sulfonylureas
Influenza Answer Questions About Antivirals for Flu Treatment
Gastroenterology Clear Up Confusion About How to Manage Diverticulitis
Cannabinoids Clarify the Buzz About Cannabidiol (CBD) for Arthritis